Electromedical Technologies, Inc.
EMED · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.00 | 0.01 | 0.00 | -0.02 |
| FCF Yield | -24.99% | -11.64% | 0.12% | -7.50% |
| EV / EBITDA | -4.88 | -11.69 | -6.07 | 17.91 |
| Quality | ||||
| ROIC | 12.63% | 4.00% | 9.86% | 12.25% |
| Gross Margin | -104.12% | -102.13% | -15.82% | -24.18% |
| Cash Conversion Ratio | 0.38 | 0.31 | -0.00 | -0.75 |
| Growth | ||||
| Revenue 3-Year CAGR | -67.80% | -60.92% | -37.92% | -20.02% |
| Free Cash Flow Growth | -635.92% | -9,708.57% | 101.23% | 7.98% |
| Safety | ||||
| Net Debt / EBITDA | -2.13 | -8.53 | -4.88 | 14.43 |
| Interest Coverage | -1.36 | -39.19 | -6.73 | -4.78 |
| Efficiency | ||||
| Inventory Turnover | 0.78 | 0.70 | 0.94 | 1.07 |
| Cash Conversion Cycle | -1,341.86 | -2,047.21 | -1,679.05 | -1,092.04 |